Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01531894
Title Continuation Study of the Oral AKT Inhibitor GSK2110183
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

Afuresertib

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.